The regulatory file for GABA: route, limits and label
GABA is supplied as gamma-aminobutyric acid, CAS 56-12-2. The catalog specification and the lot certificate describe the material; the regulatory file is built around the destination, the finished-product route and the label. The buyer's regulatory team confirms that route. This page lists the framework, the limits and the documents that belong in the review, so the specification and the commercial pack can be checked together.
The powder is the same in every market; the route, the label name and the limits are not, so the file is built for the destination.
What the file has to answer
A complete file answers four practical questions. What is the material, and which specification revision is being bought? Which lot is being released, and what does its certificate report? Which limits and label rules apply to the finished product in the destination market? And what happens to the file if the source, the route or the pack changes?
The certificate answers the lot question, the technical data sheet answers the specification question, and the safety data sheet answers the handling question. None of them answers the route question on its own. That answer depends on the destination, the dose and the finished-product category, and it is the buyer's regulatory team that confirms it against the current text.
The file should also carry the allergen and GMO statements, the origin record, the residual-solvent statement and any customer-specific declaration. Where a statement is missing, the gap should be named before the order rather than discovered at the port. A document list with version numbers is more useful than a folder of undated files.
European Union
Several instruments apply at once. General food law sets the safety obligation; the food-supplements directive sets the categories and the labelling of supplements; the labelling regulation governs the name, the ingredient list and the quantitative declaration; the contaminants regulation sets maximum levels for lead, cadmium, mercury and other substances; and the novel-food regulation governs whether an ingredient needs an authorisation because it was not used for food to a significant degree before 15 May 1997.
Which of those routes applies to a GABA lot is a question for the buyer's regulatory team, and the answer can depend on the member state and on the finished product. This page does not settle it and does not claim a status. The supplier's part is the specification, the lot data and the traceability; the buyer's part is the route and the label. As of this review the consolidated texts are the reference, and the file should record which version was checked.
United States
Amino acids are one of the statutory categories of dietary ingredient, so the supplement route is the usual starting point for a GABA product in the United States. That route brings the current good-manufacturing-practice rule for supplements, the Supplement Facts panel with its declared amount per serving, and the ingredient-identity and record-keeping duties that sit behind the panel.
Two questions are often left until late. The first is whether the ingredient needs a notification as a new dietary ingredient for the intended use; the second is whether the wording on the pack is a structure-function claim, with the notification that the rule requires. The buyer's regulatory team confirms both. The supplier can support them with the specification, the certificate and the identity evidence, and that is the limit of the supplier's role.
Great Britain and Northern Ireland
Great Britain and Northern Ireland are checked separately. The GB file uses the current GB register and GB labelling rules, while Northern Ireland follows the EU framework. The buyer's team confirms which of the two applies to the destination and keeps the evidence with the order, because the same pack can be compliant in one and not in the other.
Contaminants and the finished-product calculation
The contaminant panel is a finished-product calculation, not only a drum result. The table below is the usual starting point for a supplement file; the destination text and the daily dose decide the final limit.
| Contaminant | Typical supplement reference | What the file should show |
|---|---|---|
| Lead (Pb) | 3.0 mg/kg | Lot result, method, limit and the finished-product calculation |
| Cadmium (Cd) | 1.0 mg/kg | Lot result and any category exception that applies |
| Mercury (Hg) | 0.10 mg/kg | Lot result and method |
| Arsenic (As) | Agreed limit | The agreed figure and the method, stated on the certificate |
The dose makes the arithmetic concrete. A lot at 0.5 mg/kg lead, used at 500 mg per serving, contributes 0.25 µg of lead per serving; the same lot used at 5 g per serving contributes 2.5 µg. The specification is written per kilogram of powder, but the exposure is written per serving, and the two have to be joined in the file.
Label and claims
No disease-related claim is made for this material, and this page makes no health claim of any kind. The label names the substance and the amount in the form the destination requires; any structure-function or health wording is reviewed by the brand's regulatory team against the rules of the market, and the review is recorded with the artwork rather than with the certificate.
The certificate does not approve a claim, and a claim does not change the specification. The label name matters here for a second reason: the substance named on the pack has to be the substance in the drum. A product named as GABA that contains a different amino acid fails at the identity step before any claim is considered.
The document set
- Certificate of analysis for the lot, with method, limit and result for each line.
- Technical data sheet carrying the specification revision.
- Safety data sheet for handling and transport.
- Allergen statement, GMO statement and origin record.
- Residual-solvent statement and, where relevant, a non-irradiation statement.
- Change-control record for the source, the route and the pack.
Keep the version numbers together. A certificate that cites one specification revision, a data sheet that carries another and a quotation that names a third is a file that will fail an audit even when the powder is correct.
Checklist before the first order
- The substance, the CAS number and the specification revision are named.
- The certificate, data sheet and safety data sheet are on file with dates.
- The contaminant results are converted to the finished-product dose.
- The label name and any claim have been reviewed for the destination.
- The GB and EU routes have been checked separately where both apply.
- Source, route and pack are under change control.
The product page carries the catalog specification; the COA page explains the lot certificate; the identity page covers the analytical evidence; the MOQ page covers the order. The quality page describes the release file, and the methods library describes the tests behind the numbers.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation